FindTrial
Sign In

The case report and risk factor analysis of high-grade chronic immune-related pneumonia caused by anti-programmed cell death receptor 1

The case report and risk factor analysis of high-grade chronic immune-related pneumonia caused by anti-programmed cell death receptor 1

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050525
Enrollment
Unknown
Registered
2021-08-28
Start date
2021-08-26
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immune checkpoint associated pneumonia

Interventions

Case series:None

Sponsors

The First Affiliated Hospital of Hebei North University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: The use of immune checkpoint inhibitors has chronic immune-related adverse reactions in the lungs.

Exclusion criteria

Exclusion criteria: The first pneumonia was not cured, leading to death

Design outcomes

Primary

MeasureTime frame
Immune-related pneumonia recurrence time;Blood routine;—

Countries

China

Contacts

Public ContactWang Yuandi

The First Affiliated Hospital of Hebei North University

1033862028@qq.con+86 18820127435

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026